News

Pharmabiz36m
Sandoz signs non-binding term sheet with Evotec to acquire its Just-Evotec Biologics in-house development and manufacturing for USD 300 million
Sandoz signs non-binding term sheet with Evotec to acquire its Just-Evotec Biologics in-house development and manufacturing for USD 300 million: Basel Thursday, July 31, 2025, 12: ...
Pharmabiz1h
NIH researchers develop AI agent that improves accuracy of gene set analysis by leveraging expert-curated databases
NIH researchers develop AI agent that improves accuracy of gene set analysis by leveraging expert-curated databases: Maryland Thursday, July 31, 2025, 11:00 Hrs [IST] Researchers ...
Pharmabiz3h
US FDA takes steps to restrict 7-hydroxymitragynine opioid products threatening American consumers
US FDA takes steps to restrict 7-hydroxymitragynine opioid products threatening American consumers: Silver Spring, Maryland Thursday, July 31, 2025, 09:00 Hrs [IST] The US Food an ...
Pharmabiz18h
PCRM survey shows 91% of adults prefer a plant-based diet over injectable drugs for weight loss
PCRM survey shows 91% of adults prefer a plant-based diet over injectable drugs for weight loss: Our Bureau, Bengaluru Wednesday, July 30, 2025, 17:45 Hrs [IST] Physicians Committ ...
Pharmabiz20h
Veranova appoints Thomas Rohrer as vice president of bioconjugation
Veranova appoints Thomas Rohrer as vice president of bioconjugation: Devens, Massachusetts Wednesday, July 30, 2025, 16:00 ...
Pharmabiz22h
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy: Paris, France Wednesday, July 30, ...
Pharmabiz18h
Alfasigma announces positive results from OLINGUITO phase 3 trial of filgotinib to treat adult patients with active axial spondyloarthritis
Alfasigma announces positive results from OLINGUITO phase 3 trial of filgotinib to treat adult patients with active axial spondyloarthritis: Bologna Wednesday, July 30, 2025, 18:0 ...
Pharmabiz19h
AI adoption surges in life sciences manufacturing as talent, risk, and quality pressures intensify
AI adoption surges in life sciences manufacturing as talent, risk, and quality pressures intensify: Our Bureau, Mumbai Wednesday, July 30, 2025, 16:50 Hrs [IST] Rockwell Automatio ...
Pharmabiz23h
Ofichem expands drug substance capabilities with acquisition of Meribel Pharma Solutions’ Uppsala site in Sweden
Ofichem expands drug substance capabilities with acquisition of Meribel Pharma Solutions’ Uppsala site in Sweden: Ter Apel, Netherlands Wednesday, July 30, 2025, 13:00 Hrs [IST] ...
Pharmabiz19h
Zydus Wellness posts net sales of Rs. 8,577 million in Q1FY26
Zydus Wellness posts net sales of Rs. 8,577 million in Q1FY26: Our Bureau, Mumbai Wednesday, July 30, 2025, 17:15 Hrs [IST] Reporting its first quarter results for FY 26, Zydus We ...
Pharmabiz21h
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria: Warren, New Jersey Wednesday, July 30, 2025, 15:00 Hrs [IST] PTC Therapeuti ...
Pharmabiz19h
SPPSPTM hosts Orientation Programme 2025 to welcome future pharma professionals
SPPSPTM hosts Orientation Programme 2025 to welcome future pharma professionals: Our Bureau, Mumbai Wednesday, July 30, 2025, 17:30 Hrs [IST] The induction programme 2025 for new ...